Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hyperthermia 1 Breast Neoplasms 1

Interventions

Specimen Handling 84 Magnetic Resonance Spectroscopy 83 Cyclophosphamide 77 pembrolizumab 64 Radiotherapy 58 Nivolumab 55 fludarabine 47 Cisplatin 45 Biopsy 41 Carboplatin 40 Standard of Care 36 Dexamethasone 33 Rituximab 30 Radiation 30 Bevacizumab 30 Radiosurgery 29 Temozolomide 28 Gemcitabine 28 Surveys and Questionnaires 27 Doxorubicin 27 Cytarabine 27 Paclitaxel 26 venetoclax 25 fludarabine phosphate 25 Blood Specimen Collection 25 Practice Guidelines as Topic 24 Ipilimumab 24 Interviews as Topic 21 Fluorouracil 21 atezolizumab 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × AC protocol × 30 days × Clear all

NCT05889390 2026-05-15

NeoHTerMa

Semmelweis University

Phase 2/3 Active not recruiting

Hyperthermia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡